Announcements

Journal of Personalized Medicine (JPM; ISSN: 2075-4426) is an international journal published monthly online by the leading open access publisher MDPI with Prof. Dr. David Alan Rizzieri serving as the Editor-in-Chief. JPM publishes cutting-edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, and ‘omics association analysis). To ensure the continued efficient and high-quality production of our journal, we are currently seeking nominations and applications for the position of Co-Editor-in-Chief to assist Prof. Dr. David Alan Rizzieri.

The responsibilities of the Co-Editor-in-Chief include the following:

• Advising on the strategic development of the journal;
• Nominating/inviting Guest Editors and optionally delegating to them the authority to make final acceptance decisions for submitted articles;
• Nominating and leading the Editorial Board;
• Promoting the journal at scientific conferences or through other venues.

As an Co-Editor-in-Chief, you will have the unique opportunity to network and communicate with scholars in the personalized medicine community, building long-term relationships and establishing your influence within your discipline. Appointed members will also receive an Editor Certificate confirming this role. In addition, you will have the opportunity to publish two paper per year free of charge in JPM. The term for this position is two years and can be renewed.

If you are a researcher in a related field and are passionate about participating in the publication of cutting-edge research, please do not hesitate to get in touch about joining the Editorial Board (https://www.mdpi.com/journal/jpm). To apply for this position, please contact the Journal of Personalized Medicine Editorial Office (jpm@mdpi.com) with the following two files attached:

• A full academic CV;
• A short cover letter that details your interests and enthusiasm for the position.

JPM Editorial Office

The Journal of Personalized Medicine (JPM, ISSN: 2075-4426) editorial team is pleased to announce the launch of a new Section, “Life-Stage-Specific Medicine (LSSM)”. The aim of this Section is to offer a platform for researchers and professionals in the field of personalized medicine on which they can demonstrate the influence of genetic and environmental factors on different life stages, in addition to how different life stages affect disease development, treatments, and longevity.

Topics could include, but are not limited to, the following:

• Disease development of different life stages and responses to disease treatments;
• Hormone levels in different life stages and their impact on disease development and treatments;
• The immune system at different life stages and its relationship with disease development, drugs, and disease treatments;
• Changes in hormone levels and immune statements during translations of life stages;
• How the length of life stages affects the total lifespan of humans;
• Clinical practice, clinical trials, and drug dosages with regard to the principal law of lifespan (PLOSP);
• Racial and sex differences in terms of life stages and lifespan;
• Menopause; puberty; and reproduction.

We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at jpm@mdpi.com. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/786489cd3ae44f21e922b7fa879d33fc?form%5Bjournal_id%5D=65.

JPM Editorial Office

Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan

MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.

The following MDPI journals will be represented:

• Biomedicines;
• JPM;
• Pharmaceutics;
• JCM;
• Pharmaceuticals.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.

The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.

As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.

MDPI's Preprints Platform – Preprints.org

To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.

During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.

We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.

For more information, please visit Preprints.org.

Conference: 11th National Conference on Bioinformatics and Systems Biology
Date: 25–27 February 2023
Place: Guangzhou, China

MDPI will be attending the 11th National Conference on Bioinformatics and Systems Biology (CCBSB2023) as the exhibitor. The National Academic Conference on Bioinformatics and Systems Biology has been successfully held for ten sessions since its first session in 1998. It is a national event with the highest academic level and the greatest influence in the field of bioinformatics research in China. The theme of the conference is "The Latest Frontier Research of Bioinformatics and Systems Biology and Their Applications", and the topics cover translational informatics and data sharing security, biomedical data mining and computing, genome informatics, artificial intelligence and life sciences, group bioinformatics and integrated biology, non-coding RNA and RNA informatics, network biology, major disease omics informatics, biological macromolecular structure prediction and simulation, bioinformatics algorithm research, biological data resources, bioinformatics and drugs discovery, computational synthetic biology, agricultural and forestry informatics and other bioinformatics, and other frontier directions.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Cardiogenetics;
• Bioengineering;
• Biomolecules;
• Metabolites;
• Cells;
• Symmetry;
• Biomedicines;
• Computers;
• COVID;
• Epigenomes.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://ccbsb2022.casconf.cn/.

We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.

This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.

The mentee’s responsibilities include:

• Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
• Writing a brief promotion plan for the Special Issue;
• Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
• Writing an editorial for the online Special Issue together with the mentor.

The mentor’s responsibilities include:

• Conducting a final check before the Special Issue is published online;
• Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
• Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
• Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
• Making and submitting decisions regarding submissions with the assistance of mentees.

Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.

If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.

In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.

MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.

This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.

Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.

Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.

Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.

As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.

A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.

MDPI is proud to be the leading agent of the transition to open access.

"Thanks a Million" to all the contributors!

We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.

The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).

The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.

Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.

MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.

The following MDPI journals will be represented:

• Children (leading journal);
• JPM;
• Medicina;
• Audiology Research;
• JCM;
• Healthcare;
• Diagnostics;
• Metabolites;
• Cancers;
• Nutrients. 

If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have. 

For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.

This program intends to provide an opportunity for early career scientists to enhance their editing, networking, and organizational skills, and to work closely with our journal to gain more editorial experience. Early career scientists who have novel ideas for new Special Issues in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) will act as Guest Editors under the mentorship of an experienced scientist; this mentor could be a member of the Editorial Board of JPM, or from other well-established research institutes or laboratories.

If you are interested in this opportunity, please send your Special Issue proposal to the JPM Editorial Office (jpm@mdpi.com), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.

In addition to the new Special Issue Mentor Program, JPM will continue to welcome all Special Issue proposals based on hot research topics.